rtd banner 0821.jpg

Patient Care Is
Your Priority.
It's Ours Too.

Innovative Solutions for Improving Patient Care


Headquartered in the USA, Keneric Healthcare is a medical device company that is recognized by healthcare executives and clinicians for the development and provision of innovative products that improve patient care, increase clinician efficiency and streamline facility expenditures.

Our commitment to innovation is exemplified in the development of RTD™ Wound Dressing which is a truly unique polyurethane foam dressing that consistently demonstrates positive clinical outcomes for a variety of wound types.

RTD™ Wound Dressing is indicated for the treatment of partial to full thickness wounds with light to heavy exudate, including pressure injuries, venous stasis ulcers, diabetic foot ulcers, and any other wound inflicted by trauma.

Keneric Healthcare is a vibrant company that is committed to providing products that enhance the lives of patients, clinicians and care givers alike.


Keneric Healthcare is accredited to ISO 13485 by TUV NORD. Design, Development, Manufacturing and Distribution of Wound Care Products.


TUV NORD has granted CE Class IIb classification to Keneric Healthcare’s RTD™ Wound Dressing. Obelis SA is Keneric Healthcare’s EU representative.


Informational Video

Featured Case Study

A Versatile Dressing  For Treating Acute & Chronic Wounds

  • Creates Optimal Environment for Wound Healing

  • Light to Heavy Exudate

  • Effective for Pressure Ulcers, Venous Stasis Ulcers and Diabetic Foot Ulcers

  • Ready to Apply and Easy to Use

  • Increase Clinician Efficiency

  • Streamline Facility Expenditures

request sample doctor.jpg

Sustained Antimicrobial Effectiveness

Active ingredients: Silver, Methylene Blue and Gentian Violet

  • Draws protein rich exudate away from wound; creates a favorable wound healing environment

  • Effective antimicrobial and antifungal properties; reduces bacterial load

  • Early and sustained antimicrobial protection; helps prevent biofilm

  • Analgesic; significant pain reduction reported

  • Non-cytotoxic; use throughout the continuum of care

  • Cost effective; reduces healing time; use up to 3 days